- Home
- TIGR vs TARS Comparison
TIGR vs TARS Comparison
Compare TIGR & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGR
- TARS
- Stock Information
- Founded
- TIGR 2014
- TARS 2016
- Country
- TIGR Singapore
- TARS United States
- Employees
- TIGR N/A
- TARS N/A
- Industry
- TIGR Investment Bankers/Brokers/Service
- TARS Medicinal Chemicals and Botanical Products
- Sector
- TIGR Finance
- TARS Health Care
- Exchange
- TIGR Nasdaq
- TARS Nasdaq
- Market Cap
- TIGR 1.9B
- TARS 1.7B
- IPO Year
- TIGR 2019
- TARS 2020
- Fundamental
- Price
- TIGR $10.41
- TARS $52.72
- Analyst Decision
- TIGR Strong Buy
- TARS Strong Buy
- Analyst Count
- TIGR 2
- TARS 7
- Target Price
- TIGR $10.79
- TARS $67.14
- AVG Volume (30 Days)
- TIGR 5.8M
- TARS 670.6K
- Earning Date
- TIGR 08-29-2025
- TARS 08-06-2025
- Dividend Yield
- TIGR N/A
- TARS N/A
- EPS Growth
- TIGR 93.97
- TARS N/A
- EPS
- TIGR 0.46
- TARS N/A
- Revenue
- TIGR $374,147,409.00
- TARS $295,521,000.00
- Revenue This Year
- TIGR $53.82
- TARS $122.94
- Revenue Next Year
- TIGR $13.18
- TARS $44.14
- P/E Ratio
- TIGR $21.98
- TARS N/A
- Revenue Growth
- TIGR 61.42
- TARS 254.45
- 52 Week Low
- TIGR $3.39
- TARS $24.95
- 52 Week High
- TIGR $14.48
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- TIGR 57.03
- TARS 76.67
- Support Level
- TIGR $9.13
- TARS $40.55
- Resistance Level
- TIGR $10.21
- TARS $42.11
- Average True Range (ATR)
- TIGR 0.45
- TARS 2.02
- MACD
- TIGR -0.02
- TARS 1.30
- Stochastic Oscillator
- TIGR 71.91
- TARS 98.61
About TIGR UP Fintech Holding Ltd representing fifteen
UP Fintech Holding Ltd is an online brokerage firm focusing on Chinese investors. Its trading platform enables investors to trade in equities and other financial instruments on multiple exchanges of stocks and other derivatives. The company offers its customers brokerage and value-added services, including trade order placement and execution, margin financing, account management, investor education, community discussion, and customer support.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.